跳至主要内容
临床试验/CTRI/2024/08/072019
CTRI/2024/08/072019尚未招募不适用

To evaluate the in-vivo safety and efficacy of skin care formulation in terms of reduction in Dark circles, wrinkles, under eye puffiness and improvement in hydration on healthy female subjects.

Mountain valley springs India pvt. ltd.1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2024年8月16日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
36
试验地点
1
主要终点
Reduction in Dark circles, wrinkles, under eye puffiness and improvement in hydration

研究概览

简要总结

The objective of this study will be to evaluate the in-vivo safety and efficacy of skin care formulation in terms of reduction in Dark circles, wrinkles, under eye puffiness and improvement in hydration on healthy female subjects

The evaluation is performed using: Subject Self Evaluation, Dermatological Evaluation: Cosmetic Acceptability, Dermatological Evaluation: Efficacy, Mexametry, Corneometry, Illustrative Images of the whole face & 3/4th face under diffuse light

The study last 56 days following the first application of the product.

POPULATION: 36 female subjects will be selected for the study.

The subjects selected for this study are healthy females, aged between 35 and 55 years, Having mild to moderate dark circles.Having Crows feet wrinkle of grade 2-4 on basis of Skin ageing Atlas. Having visible under eye puffiness.

研究设计

研究类型
Interventional
分配方式
Na
盲法
Participant Blinded

入排标准

年龄范围
35.00 Year(s) 至 55.00 Year(s)(—)
性别
Female

入选标准

  • Indian female subjects
  • Healthy subjects
  • Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….)
  • Having mild to moderate dark circles.
  • Having Crows feet wrinkle of grade 2-4 on basis Skin ageing Atlas.
  • Having visible under eye puffiness.

排除标准

  • Being pregnant or breastfeeding or having stopped to breastfeed in the past three months
  • Having refused to give her assent by not signing the consent form
  • Taking part in another study liable to interfere with this study
  • Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less than 6 months)
  • Having a progressive asthma (either under treatment or last fit in the last 2 years)
  • Being epileptic.
  • Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months)
  • Having cutaneous hypersensitivity
  • Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.
  • Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol)
  • Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.

结局指标

主要结局

Reduction in Dark circles, wrinkles, under eye puffiness and improvement in hydration

时间窗: Baseline, Day14, Day28, Day56

次要结局

未报告次要终点

研究者

发起方
Mountain valley springs India pvt. ltd.
申办方类型
Other [fmcg]
责任方
Principal Investigator
主要研究者

Dr Pooja Yadav

MASCOT-SPINCONTROL India Pvt. Ltd.

研究点 (1)

Loading locations...

相似试验